Displaying 51 - 74 of 74 results
Released Company Title Industry Topic
01 Dec 2023
08:46 CET
EXACT THERAPEUTICS EXACT Therapeutics AS: Primary insider notices 20103010 Biotechnology Mandatory notification of trade primary insiders
30 Nov 2023
22:30 CET
EXACT THERAPEUTICS EXACT Therapeutics AS: Private placement successfully placed 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 Nov 2023
16:30 CET
EXACT THERAPEUTICS EXACT Therapeutics AS: Contemplated Private Placement 20103010 Biotechnology Inside information
31 Oct 2023
10:48 CET
EXACT THERAPEUTICS EXACT Therapeutics receives regulatory approval to start recruitment of patients at Oslo University hospital 20103010 Biotechnology Non-regulatory press releases
16 Oct 2023
16:35 CEST
EXACT THERAPEUTICS EXACT Therapeutics AS – Issuance of share options 20103010 Biotechnology Mandatory notification of trade primary insiders
12 Oct 2023
08:49 CEST
EXACT THERAPEUTICS EXACT Therapeutics CEO Dr Per Walday to participate in international Drug Delivery panel 20103010 Biotechnology Non-regulatory press releases
28 Sep 2023
08:00 CEST
EXACT THERAPEUTICS EXACT Therapeutics announces first half 2023 interim results 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
27 Sep 2023
14:55 CEST
EXACT THERAPEUTICS EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development 20103010 Biotechnology Non-regulatory press releases
26 Sep 2023
08:30 CEST
EXACT THERAPEUTICS EXACT Therapeutics announces positive clinical results from the ACTIVATE Phase I dose escalation 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
19 Sep 2023
08:41 CEST
EXACT THERAPEUTICS Invitation to first half results 2023 presentation of EXACT Therapeutics AS 20103010 Biotechnology Non-regulatory press releases
13 Sep 2023
09:16 CEST
EXACT THERAPEUTICS Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
06 Sep 2023
09:48 CEST
EXACT THERAPEUTICS EXACT Therapeutics and Cordance Medical Announce Strategic Partnership to Revolutionize Drug Delivery to the Brain 20103010 Biotechnology Non-regulatory press releases
07 Aug 2023
09:57 CEST
EXACT THERAPEUTICS EXACT Therapeutics completed the dose escalation part of ACTIVATE study 20103010 Biotechnology Non-regulatory press releases
31 Jul 2023
13:02 CEST
EXACT THERAPEUTICS EXACT Therapeutics receives regulatory approval to start the dose expansion part of ACTIVATE study 20103010 Biotechnology Non-regulatory press releases
09 Jun 2023
12:39 CEST
EXACT THERAPEUTICS EXACT Therapeutics minutes from Annual General Meeting June 9, 2023 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
31 May 2023
09:14 CEST
EXACT THERAPEUTICS EXACT Therapeutics AS - Notice of Annual General Meeting 2023 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 May 2023
11:43 CEST
EXACT THERAPEUTICS EXACT Therapeutics Announces Granted Patent in United Kingdom for Acoustic Cluster Therapy (ACT®) 20103010 Biotechnology Non-regulatory press releases
21 Apr 2023
17:42 CEST
EXACT THERAPEUTICS EXACT Therapeutics AS announces the publication of the 2022 Annual Report 20103010 Biotechnology Annual financial and audit Reports
28 Mar 2023
08:30 CEST
EXACT THERAPEUTICS EXACT Therapeutics presents encouraging clinical case report data at Science & Technology Event 20103010 Biotechnology Non-regulatory press releases
02 Feb 2023
13:13 CET
EXACT THERAPEUTICS Exact Therapeutics receives regulatory approval to reopen the ACTIVATE clinical trial 20103010 Biotechnology Non-regulatory press releases
13 Jan 2023
09:42 CET
EXACT THERAPEUTICS Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Jan 2023
09:20 CET
EXACT THERAPEUTICS EXACT Therapeutics AS – Mandatory notification of trade by primary insiders 20103010 Biotechnology Mandatory notification of trade primary insiders
03 Jan 2023
16:06 CET
EXACT THERAPEUTICS EXACT Therapeutics AS – Issuance of share options 20103010 Biotechnology Mandatory notification of trade primary insiders
22 Dec 2022
08:45 CET
EXACT THERAPEUTICS Exact Therapeutics awarded NOK 16 million from Norwegian Research Council for collaboration project with NTNU, ICR and TGen 20103010 Biotechnology Non-regulatory press releases